We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.41%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2B
AUM Growth
-$231M
(-10%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-10.69%
Top 10 Holdings %
Top 10 Hldgs %
6.82%
Holding
1,904
New
580
Increased
368
Reduced
360
Closed
591
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$13.5M |
| 2 |
Amgen
AMGN
|
+$13.4M |
| 3 |
Charter Communications
CHTR
|
+$12M |
| 4 |
Amazon
AMZN
|
+$11M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$20M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$19.3M |
| 3 |
Pfizer
PFE
|
+$19.2M |
| 4 |
Alkermes
ALKS
|
+$14.8M |
| 5 |
Visa
V
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.12% |
| 2 | Healthcare | 11.46% |
| 3 | Technology | 11.32% |
| 4 | Industrials | 11.2% |
| 5 | Materials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Edwards Lifesciences
EW
$47.6B
| $4M | 0.2% |
120,210
-42,000
| -26% | -$1.44M |
|
127
Ironwood Pharmaceuticals
IRWD
$611M
| $3.98M | 0.2% |
363,233
+126,087
| +53% | +$1.23M |
|
128
Oshkosh
OSK
$9.67B
| $3.96M | 0.2% |
+83,024
| New | +$3.68M |
|
129
Coca-Cola Europacific Partners
CCEP
$46.5B
| $3.96M | 0.2% |
+110,908
| New | +$5.23M |
|
130
Sabre
SABR
$656M
| $3.91M | 0.2% |
+145,963
| New | +$4.1M |
|
|
GPOR
131
DELISTED
Gulfport Energy Corp.
GPOR
| $3.88M | 0.19% |
+124,292
| New | +$3.76M |
|
132
PG&E
PCG
$47.8B
| $3.87M | 0.19% |
60,609
-5,000
| -8% | -$299K |
|
|
KATE
133
DELISTED
Kate Spade & Company
KATE
| $3.86M | 0.19% |
187,529
+140,788
| +301% | +$3.21M |
|
|
OCLR
134
DELISTED
Oclaro Inc.
OCLR
| $3.86M | 0.19% |
791,589
+678,074
| +597% | +$3.37M |
|
|
IMS
135
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $3.85M | 0.19% |
+151,687
| New | +$3.89M |
|
136
VeriSign
VRSN
$25.3B
| $3.82M | 0.19% |
44,186
+35,800
| +427% | +$3.09M |
|
|
VALE.P
137
DELISTED
Vale S A
VALE.P
| $3.81M | 0.19% |
950,843
+528,629
| +125% | +$1.94M |
|
138
Edison International
EIX
$30.7B
| $3.79M | 0.19% |
48,849
+2,800
| +6% | +$201K |
|
139
AES
AES
$10.6B
| $3.77M | 0.19% |
302,088
-402,318
| -57% | -$4.53M |
|
|
MRC
140
DELISTED
MRC Global
MRC
| $3.76M | 0.19% |
264,834
+166,776
| +170% | +$2.31M |
|
141
Louisiana-Pacific
LPX
$5.2B
| $3.75M | 0.19% |
+216,085
| New | +$3.81M |
|
|
ETFC
142
DELISTED
E*Trade Financial Corporation
ETFC
| $3.74M | 0.19% |
+159,364
| New | +$4.04M |
|
143
AMC Global Media
AMCX
$430M
| $3.73M | 0.19% |
+61,798
| New | +$3.93M |
|
144
Bruker
BRKR
$9.2B
| $3.71M | 0.19% |
163,099
+123,646
| +313% | +$3.3M |
|
145
Pan American Silver
PAAS
$18.6B
| $3.67M | 0.18% |
222,939
+125,465
| +129% | +$1.8M |
|
146
Myriad Genetics
MYGN
$530M
| $3.65M | 0.18% |
119,317
+105,300
| +751% | +$3.66M |
|
147
Builders FirstSource
BLDR
$7.84B
| $3.65M | 0.18% |
+324,111
| New | +$3.74M |
|
148
AGNC Investment
AGNC
$12.3B
| $3.55M | 0.18% |
+179,329
| New | +$3.38M |
|
|
WCG
149
DELISTED
Wellcare Health Plans, Inc.
WCG
| $3.51M | 0.18% |
32,715
-43,400
| -57% | -$4.24M |
|
|
BERY
150
DELISTED
Berry Global Group, Inc.
BERY
| $3.47M | 0.17% |
97,333
+57,391
| +144% | +$1.96M |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, A.R.T. Advisors held 1,904 positions worth $2B, down 10% from $2.24B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
A.R.T. Advisors withdrew a net $214M in Q2 2016, closing 591 positions and reducing 360 holdings. Its most notable exit was Johnson & Johnson, an estimated $20M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
Against the trend, A.R.T. Advisors opened a new position in Mastercard worth $12.4M.
- A.R.T. Advisors's largest Q2 2016 buy was Mastercard: 141,390 shares worth $12.4M.
- A.R.T. Advisors added most to Paramount Global Class B in Q2 2016, an estimated $8.3M increase.
- A.R.T. Advisors's biggest Q2 2016 reduction was Visa, cutting an estimated $12.8M.
- A.R.T. Advisors fully exited Johnson & Johnson in Q2 2016, selling an estimated $20M.
- A.R.T. Advisors's ten largest holdings make up 6.8% of its $2B portfolio in Q2 2016.
- A.R.T. Advisors opened 580 new positions and closed 591 in Q2 2016.
- A.R.T. Advisors's portfolio value fell 10% quarter-over-quarter to $2B.
Based on A.R.T. Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.